Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marinus Pharma receives new US patent for Ganaxolone
The new patent entitled, ‘Solid Ganaxolone formulations and methods for the making and use thereof,’ describes a novel class of small molecules to improve stability and bioavailability of
The new patent entitled, ‘Solid Ganaxolone formulations and methods for the making and use thereof,’ describes a novel class of small molecules to improve stability and bioavailability of
The first trail results showed that VB-111 was safe and specific and may offer additive effect to chemotherapy. In the trial, the researchers investigated the safety and efficacy
SIRO Clinpharm, a global clinical research organizations (CRO), offers full scope services, conducting clinical trials in the pharmaceutical, biotechnology and medical devices sectors. The company has offices in
The study of AVL-292-001 was a double-blind, placebo-controlled, single ascending dose study in healthy volunteers and in this study AVL-292 demonstrated favorable safety, tolerability and pharmacokinetics. In addition,
Pollinex Quattro is a four injection therapeutic vaccine for the treatment of allergic conditions which offers same season relief in as little as three weeks after treatment. Following
OctoPlus is a European provider of advanced drug formulation and clinical scale manufacturing services to the pharmaceutical and biotechnology industries. As per the agreement OctoPlus is expected to
SYN115 is an orally bioavailable, potent and selective adenosine A2a receptor antagonist, which enters the brain and modulates regions associated with motor and non-motor function. Biotie obtained development
The company has submitted another patent application covering protection for the T36 formula in combination with anesthetics, analgesics and anti-inflammatories as a treatment for a range of topical
Elidel is an immuno-suppressant which helps to slow down the growth of atopic dermatitis (eczema) on the skin. As per the terms of the agreement, Meda is responsible
Astrazeneca said the safety and effectiveness of Vandetanib were proved in a single randomised international study of 331 patients with late-stage medullary thyroid cancer, who were selected to